North Rock Partners, LLC Abb Vie Inc. Transaction History

North Rock Partners, LLC

$1.14 Billion
Q3 2024

A detailed history of North Rock Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, North Rock Partners, LLC holds 17,613 shares of ABBV stock, worth $3.59 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

17,613

Previous 23,676 25.61%

Holding current value

$3.59 Million

Previous $4.06 Million 14.33%

% of portfolio

0.31%

Previous 0.35%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$163.84 - $199.33 $993,361 - $1.21 Million	-6,063 Reduced 25.61%	17,613 $3.48 Million
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $250,140 - $292,108	-1,616 Reduced 6.39%	23,676 $4.06 Million
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $276,168 - $314,668	1,728 Added 7.33%	25,292 $4.61 Million
Q4 2023 Feb 08, 2024	BUY	$137.6 - $154.97 $65,360 - $73,610	475 Added 2.06%	23,564 $3.65 Million
Q3 2023 Oct 24, 2023	BUY	$133.59 - $154.65 $266,244 - $308,217	1,993 Added 9.45%	23,089 $3.44 Million
Q2 2023 Aug 02, 2023	SELL	$132.51 - $164.9 $694,219 - $863,911	-5,239 Reduced 19.89%	21,096 $2.84 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $127,979 - $147,387	885 Added 3.48%	26,335 $4.2 Million
Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $646,599 - $775,442	-4,675 Reduced 15.52%	25,450 $4.12 Million
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $262,648 - $301,241	-1,957 Reduced 6.1%	30,125 $4.04 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $472,587 - $600,812	-3,434 Reduced 9.67%	32,082 $4.91 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $4.68 Million - $5.81 Million	-35,487 Reduced 49.98%	35,516 $5.76 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $260,088 - $329,086	2,421 Added 3.53%	71,003 $9.61 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $375,485 - $426,232	3,529 Added 5.42%	68,582 $7.5 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $14,834 - $16,526	-141 Reduced 0.22%	65,053 $7.33 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $111,097 - $122,305	-1,086 Reduced 1.64%	65,194 $7.06 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $153,091 - $206,690	1,902 Added 2.95%	66,280 $7.1 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $17,182 - $20,166	200 Added 0.31%	64,378 $5.64 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $101,250 - $135,488	-1,380 Reduced 2.11%	64,178 $6.3 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $282,914 - $378,582	3,856 Added 6.25%	65,558 $6.3 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $1.62 Million - $2.45 Million	25,097 Added 68.56%	61,702 $4.7 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $288 - $361	4 Added 0.01%	36,605 $3.24 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $948,293 - $1.19 Million	13,147 Added 56.05%	36,601 $3.24 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $1.48 Million - $1.78 Million	23,454 New	23,454 $1.78 Million

Others Institutions Holding ABBV

# of Institutions

3,767

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $360B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.

Account

North Rock Partners, LLC Abb Vie Inc. Transaction History